{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:16:42Z","timestamp":1760145402966,"version":"build-2065373602"},"reference-count":33,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Insulinoma is the most common functional neuroendocrine tumor of the pancreas, with the main clinical symptom being hypoglycemia. The standard treatment is surgery, but some patients are not eligible for surgery, while in those operated on, the risk of perioperative complications is up to 30%. Diazoxide treatment to prevent hypoglycemia is effective only in 50% of patients. To prevent tumor growth and hormonal excess, stereotactic radiotherapy may be an alternative to surgical treatment. In our paper, we present two cases of patients with insulinoma treated successfully with stereotactic body radiation therapy (SBRT).<\/jats:p>","DOI":"10.3390\/curroncol31070307","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T13:10:28Z","timestamp":1721913028000},"page":"4123-4132","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Stereotactic Body Radiation Therapy for Symptomatic Pancreatic Insulinoma: Two-Case Report and Literature Review"],"prefix":"10.3390","volume":"31","author":[{"given":"Agnieszka","family":"Namysl-Kaletka","sequence":"first","affiliation":[{"name":"Radiotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Wydmanski","sequence":"additional","affiliation":[{"name":"Radiotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwona","family":"Debosz-Suwinska","sequence":"additional","affiliation":[{"name":"Radiotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata","family":"Kaszuba","sequence":"additional","affiliation":[{"name":"Radiology and Diagnostic Imaging Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9096-2788","authenticated-orcid":false,"given":"Dorota","family":"Gabrys","sequence":"additional","affiliation":[{"name":"Radiotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Roch-Zniszczol","sequence":"additional","affiliation":[{"name":"Radiotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0802-2880","authenticated-orcid":false,"given":"Daria","family":"Handkiewicz-Junak","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3748\/wjg.v19.i6.829","article-title":"Diagnosis and management of insulinoma","volume":"19","author":"Okabayashi","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000098010","article-title":"Diego FeroneFrascati Consensus Conference; European Neuroendocrine Tumor Society: Well-differentiated pancreatic tumor\/carcinoma: Insulinoma","volume":"84","author":"Niederle","year":"2006","journal-title":"Neuroendocrinology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/bjs.5280","article-title":"The management of insulinoma","volume":"93","author":"Tucker","year":"2006","journal-title":"Br. J. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.crad.2005.06.005","article-title":"Multimodality preoperative imaging of pancreatic insulinomas","volume":"60","author":"McAuley","year":"2005","journal-title":"Clin. Radiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.5603\/EP.a2022.0050","article-title":"Pancreatic neuroendocrine neoplasms\u2014Update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne trzustki\u2014Uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polsk\u0105 Sie\u0107 Guz\u00f3w Neuroendokrynych)]","volume":"73","author":"Rosiek","year":"2022","journal-title":"Endokrynol. Pol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.hpb.2021.04.013","article-title":"Surgical management of insulinoma over three decades","volume":"23","author":"Challine","year":"2021","journal-title":"HPB"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1245\/s10434-014-4036-4","article-title":"The 90-day mortality after pancreatectomy for cancer is double the 30- day mortality: More than 20,000 resections from the national cancer data base","volume":"21","author":"Swanson","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.hpb.2019.10.2443","article-title":"Should all pancreatic surgery be centralized regardless of patients\u2019 comorbidity?","volume":"22","author":"Lenne","year":"2020","journal-title":"HPB"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/SLA.0000000000003532","article-title":"Specificity of procedure volume and its association with post operative mortality in digestive cancer surgery: A nationwide study of 225,752 patients","volume":"270","author":"Lenne","year":"2019","journal-title":"Ann. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e13318","DOI":"10.1111\/jne.13318","article-title":"European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes","volume":"35","author":"Hofland","year":"2023","journal-title":"J. Neuroendocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/MPA.0000000000001569","article-title":"Effectiveness of Liver-Directed Therapy for the Management of Intractable Hypoglycemia in Metastatic Insulinoma","volume":"49","author":"Habibollahi","year":"2020","journal-title":"Pancreas"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"NP14","DOI":"10.1177\/1553350611418990","article-title":"Image-guided robotic radiosurgery (Cyber Knife) for pancreatic insulinoma: Is laparoscopy becoming old?","volume":"19","author":"Huscher","year":"2012","journal-title":"Surg. Innov."},{"key":"ref_13","first-page":"1302","article-title":"Insulinomas: From diagnosis to treatment. A review of the literature","volume":"25","author":"Giannis","year":"2020","journal-title":"J. BUON"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1634\/theoncologist.2008-0259","article-title":"Neuroendocrine tumors of the pancreas","volume":"14","author":"Ehehalt","year":"2009","journal-title":"Oncologist"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00423-016-1496-y","article-title":"Diagnosis and surgical management of insulinomas in 33 consecutive patients at a single institution","volume":"401","author":"Wei","year":"2016","journal-title":"Langenbecks Arch. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s10620-011-1912-7","article-title":"EUS-FNA for pancreatic neuroendocrine tumors: A tertiary cancer center experience","volume":"57","author":"Atiq","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"ref_17","first-page":"111","article-title":"Preoperative imaging and localization of small sized insulinoma with EUS-guided fine needle tattoing: A case report","volume":"4","author":"Zografos","year":"2005","journal-title":"Hormones"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Calabr\u00f2, D., Argalia, G., and Ambrosini, V. (2020). Role of PET\/CT and Therapy Management of Pancreatic Neuroendocrine Tumors. Diagnostics, 10.","DOI":"10.3390\/diagnostics10121059"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1007\/s00259-018-4101-5","article-title":"Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET\/CT, SPECT\/CT and 3T MRI for the localisation of occult insulinomas: Evaluation of diagnostic accuracy in a prospective crossover imaging study","volume":"45","author":"Antwi","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/pgmj.73.864.640","article-title":"Diazoxide treatment for insulinoma: A national UK survey","volume":"73","author":"Gill","year":"1997","journal-title":"Postgrad. Med. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1507\/endocrj.EJ18-0353","article-title":"Clinical outcomes of 20 Japanese patients with insulinoma treated with diazoxide","volume":"66","author":"Niitsu","year":"2019","journal-title":"Endocr. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/14656566.2020.1845651","article-title":"Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes","volume":"22","author":"Ito","year":"2021","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_23","first-page":"1","article-title":"Small nonfunctional pancreatic neuroendocrine neoplasms: Time for a step-up treatment approach?","volume":"12","author":"Rizzatti","year":"2022","journal-title":"Endosc. Ultrasound."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"Vienna Consensus Conference participants. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Armellini, E., Facciorusso, A., and Crin\u00f2, S.F. (2023). Efficacy and Safety of Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Neuroendocrine Tumors: A Systematic Review and Metanalysis. Medicina, 59.","DOI":"10.3390\/medicina59020359"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MPA.0000000000000110","article-title":"A systematic review of localization, surgical treatment options, and outcome of insulinoma","volume":"43","author":"Mehrabi","year":"2014","journal-title":"Pancreas"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijrobp.2021.09.027","article-title":"A Story of Hypofractionation and the Table on the Wall","volume":"112","author":"Timmerman","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.18203\/2349-2902.isj20215153","article-title":"Curative treatment of pancreatic functioning insulinoma with stereotactic ablative radiation therapy: Case report","volume":"9","author":"Alsuhaibani","year":"2022","journal-title":"Int. Surg. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ijrobp.2008.01.051","article-title":"Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer","volume":"72","author":"Schellenberg","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ijrobp.2014.06.066","article-title":"Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: Outcomes and toxicity","volume":"90","author":"Pollom","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.ijrobp.2014.03.043","article-title":"Is indirect cell death involved in response of tumors to stereotactic radiosurgery and stereotactic body radiation therapy?","volume":"89","author":"Song","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2741\/4487","article-title":"Tumor abolition and antitumor immunostimulation by physico-chemical tumor ablation","volume":"22","author":"Keisari","year":"2017","journal-title":"Front. Biosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.ijrobp.2020.11.053","article-title":"Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study","volume":"109","author":"Lieverse","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/7\/307\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:20:52Z","timestamp":1760109652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/7\/307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["curroncol31070307"],"URL":"https:\/\/doi.org\/10.3390\/curroncol31070307","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2024,7,22]]}}}